News from the partners – archive
https://amr-accelerator.eu/wp-content/uploads/2021/10/BEAM-Alliance.png
2000
2000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2021-10-21 13:32:402023-07-28 14:55:5121/10/21 – How the EU Pharmaceutical Strategy could help prevent the next pandemic
https://amr-accelerator.eu/wp-content/uploads/2021/08/DZIF.png
2000
2000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2021-08-25 13:30:282023-07-28 14:56:2425/08/21 – INCATE supports the fight against antibiotic-resistant bacteria
https://amr-accelerator.eu/wp-content/uploads/2021/04/BioVersys.png
2000
2000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2021-04-14 13:18:432023-07-28 14:57:3214/04/21 – BioVersys receives €20 million in EU financing to support development of new antibiotics
https://amr-accelerator.eu/wp-content/uploads/2021/03/TB-Alliance.png
2000
2000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2021-03-30 13:09:502023-07-28 14:58:1030/03/21 – Astellas and TB Alliance Enter into a New Collaborative Research Agreement to Identify Lead Compounds for the Treatment of Tuberculosis
https://amr-accelerator.eu/wp-content/uploads/2021/02/BIOASTER.png
2000
2000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2021-02-18 13:15:522023-07-28 14:58:4618/02/21 – Antimicrobials Program Highlights 2020